Fortescue Ltd
FMG
National Australia Bank Ltd
NAB
BHP Group Ltd
BHP
ANZ Group Holdings Ltd
ANZ
CommBank
CBA
AU Stock MarketDetailed Quotes
RNV Renerve Ltd
- 0.150
- -0.015-9.09%
20min DelayNot Open Jan 8 16:00 AET
21.28MMarket Cap-7.14P/E (Static)
0.165High0.150Low539.06KVolume0.155Open0.165Pre Close81.35KTurnover0.19552wk High0.80%Turnover Ratio141.84MShares0.13052wk Low-0.021EPS TTM10.17MFloat Cap0.195Historical HighLossP/E (Static)67.82MShs Float0.130Historical Low-0.021EPS LYR9.09%Amplitude--Dividend TTM2.88P/B1Lot Size--Div YieldTTM
About Renerve Ltd Company
Renerve Ltd specializes in developing a range of ready-to-use products that are cleaner, safer and better for repairing or replacing damaged peripheral nerves, resulting in better patient outcomes. Its product candidates include NervAlign Bionic Nerve, NervAlign Nerve Graft, and NervAlign Nerve Cuff [The NervAlign Nerve Guide Matrix, The NervAlign Nerve Conduit, The NervAlign Bionic Replacement Nerve]. The company operates in New Zealand and USA. Maximum of revenue is from USA.
Company Profile
SymbolRNV
Company NameRenerve Ltd
Founded2016
MarketASX
Fiscal Year Ends06-30
Address157 Heidelberg Road
CityNorthcote
CountryAustralia
Zip Code3070
Phone+61 394823940
Websitehttps://renerve.com.au
Share RegistryAUTOMIC REGISTRY SERVICES
477 Collins Street, MELBOURNE, VIC, AUSTRALIA, 3000
1300 288 664
Company Executives
- Name
- Position
- Salary
- David Rhodes
- Executive Director and Chief Scientific Officer
- --
- David Lilja
- Chief Financial Officer and Company Secretary
- --
- Stephen Cooper
- Chairman of the Board
- --
- Michael Panaccio
- Non-Executive Director
- --
- Julian Chick
- Executive Director
- --